Dr Bradley Corr discusses what he’s most excited to hear at the SGO Annual Meeting, including new data on antibody-drug ...

Doctors are told to raise safety concerns, but some face isolation, disciplinary action, and lasting career consequences when ...

A small carefully constructed and blinded clinical trial confirms that percutaneous intervention significantly relieves angina in patients with chronic total obstruction.

The type of alcohol you drink, and how much, can have different effects on cardiovascular and overall health, a new study has found. The negative health effects of high alcohol intake are well known, ...

ND4 variant (m.11232T>C) to severe neurologic injury after sevoflurane in patients with Venezuelan maternal ancestry, prompting international alerts.

Phase 1 data suggest that WVE-007, an investigational siRNA drug given by injection, leads to reductions in visceral fat, waist circumference, and body weight.

High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.

The seemingly unassuming organ has become an emerging target for healthspan, longevity, and precision oncology.

European regulators recommended a subcutaneous formulation for a key anti-CD38 therapy, offering clinicians and patients more flexible administration options for multiple myeloma.

If passed, the Comprehensive Cancer Survivorship Act would establish a national standard of care for cancer survivors.

Although the findings are preliminary, they suggest a program like this one could help pediatric patients to manage mental health challenges.

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.